tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Co (JP:4502)
OTHER OTC:4502
Japanese Market

Takeda Pharmaceutical Co (4502) Financial Statements

Compare
6 Followers

Takeda Pharmaceutical Co Financial Overview

Takeda Pharmaceutical Co's market cap is currently ¥8.16T. The company's EPS TTM is ¥-7.83; its P/E ratio is 238.58; and it has a dividend yield of 4.11%. Takeda Pharmaceutical Co is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is ¥52.18. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T¥ 3.20T
Gross Profit¥ 2.46T¥ 2.32T¥ 2.30T¥ 2.04T¥ 1.80T
Operating Income¥ 627.54B¥ 531.42B¥ 658.29B¥ 610.50B¥ 447.61B
EBITDA¥ 1.13T¥ 927.95B¥ 1.18T¥ 1.04T¥ 1.07T
Net Income¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B¥ 376.00B
Balance Sheet
Cash & Short-Term Investments¥ 385.11B¥ 457.80B¥ 533.53B¥ 849.70B¥ 966.22B
Total Assets¥ 14.25T¥ 15.11T¥ 13.96T¥ 13.18T¥ 12.91T
Total Debt¥ 5.09T¥ 5.46T¥ 4.86T¥ 4.81T¥ 5.07T
Net Debt¥ 4.85T¥ 5.26T¥ 4.63T¥ 3.96T¥ 4.11T
Total Liabilities¥ 7.31T¥ 7.83T¥ 7.60T¥ 7.49T¥ 7.74T
Stockholders' Equity¥ 6.94T¥ 7.27T¥ 6.35T¥ 5.68T¥ 5.17T
Cash Flow
Free Cash Flow¥ 761.70B¥ 464.90B¥ 736.56B¥ 897.97B¥ 793.87B
Operating Cash Flow¥ 962.49B¥ 640.32B¥ 877.22B¥ 1.02T¥ 905.07B
Investing Cash Flow¥ -385.36B¥ -488.21B¥ -615.72B¥ -204.44B¥ 392.04B
Financing Cash Flow¥ -638.44B¥ -254.04B¥ -600.59B¥ -962.06B¥ -981.00B
Currency in JPY

Takeda Pharmaceutical Co Earnings and Revenue History

Takeda Pharmaceutical Co Debt to Assets

Takeda Pharmaceutical Co Cash Flow

Takeda Pharmaceutical Co Forecast EPS vs Actual EPS